Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.

Selected Publications

Schulman A, Bhanot G. Using Postal Change-of-Address Data to Predict Second Waves in Infections near Pandemic Epicenters. Epidemiol Infect. 2022 Mar 24:1-23. PMID:35321775.

Qureshi S, Chan N, George M, Ganesan S, Toppmeyer D, Omene C. Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker. Biomark Insights. 2022 Feb 22;17:11772719221078774. PMID:35221668.

Sabaawy HE, Ryan BM, Khiabanian H, Pine SR. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance. Carcinogenesis. 2021 Dec 31;42(12):1411-1419. PMID:34415330.

Panda A, Bhanot G, Ganesan S, Bajpai M. Gene Expression in Barrett's Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma. Cancers (Basel). 2021 Nov 27;13(23):5971. PMID:34885081.

Jalloul N, Gomy I, Stokes S, Gusev A, Johnson BE, Lindeman NI, Macconaill L, Ganesan S, Garber JE, Khiabanian H. Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing. JCO Precis Oncol. 2021 Nov 17;5:PO. PMID:34820595.

Kwon M, Rubio G, Nolan N, Auteri P, Volmar JA, Adem A, Javidian P, Zhou Z, Verzi MP, Pine SR, Libutti SK. FILIP1L Loss Is a Driver of Aggressive Mucinous Colorectal Adenocarcinoma and Mediates Cytokinesis Defects through PFDN1. Cancer Res. 2021 Nov 1;81(21):5523-5539. PMID:34417201.

Herranz D. INTERFERing T-ALL progression: a multifaceted therapy. Haematologica. 2021 Oct 14. PMID:34647445.

Tong K, Kothari OA, Haro KS, Panda A, Bandari MM, Carrick JN, Hur JJ, Zhang L, Chan CS, Xing J, Gatza ML, Ganesan S, Verzi MP. SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis. Oncogene. 2021 Oct;40(41):6034-6048. PMID:34453124.

Yu Y, Dong H, Peng Y, Welsh WJ. QSAR-Based Computational Approaches to Accelerate the Discovery of Sigma-2 Receptor (S2R) Ligands as Therapeutic Drugs. Molecules. 2021 Aug 30;26(17):5270. PMID:34500703.

Panda A, Ganesan S. Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer. Front Genet. 2021 Jul 22;12:706435. PMID:34367262.

Gorshein E, Matsuda K, Riedlinger G, Sokol L, Rodriguez-Rodriguez L, Eladoumikdachi F, Grandhi M, Ganesan S, Toppmeyer DL, Potdevin L, Toomey K, Hirshfield KM, Chan N. Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer. Case Rep Oncol. 2021 Jun 18;14(2):931-937. PMID:34248561.

Biswas A, De S. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity. Am J Physiol Cell Physiol. 2021 May 1;320(5):C750-C760. PMID:33657326.

Satagopan JM, Stroup A, Kinney AY, Dharamdasani T, Ganesan S, Bandera EV. Breast cancer among Asian Indian and Pakistani Americans: A surveillance, epidemiology and end results-based study. Int J Cancer. 2021 Apr 1;148(7):1598-1607. PMID:33099777.

Hu X, Biswas A, Sharma A, Sarkodie H, Tran I, Pal I, De S. Mutational signatures associated with exposure to carcinogenic microplastic compounds bisphenol A and styrene oxide. NAR Cancer. 2021 Mar 1;3(1):zcab004. PMID:33718875.

Qi X, Brown LG, Foran DJ, Nosher J, Hacihaliloglu I. Chest X-ray image phase features for improved diagnosis of COVID-19 using convolutional neural network. Int J Comput Assist Radiol Surg. 2021 Feb;16(2):197-206. PMID:33420641.

García-Cañaveras JC, Lancho O, Ducker GS, Ghergurovich JM, Xu X, da Silva- Diz V, Minuzzo S, Indraccolo S, Kim H, Herranz D, Rabinowitz JD. SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia. Leukemia. 2021 Feb;35(2):377-388. PMID:32382081.

Peng Y, Zhang Q, Welsh WJ. Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management. J Med Chem. 2021 Jan 14;64(1):890-904. PMID:33372782.

Tottone L, Lancho O, Loh JW, Singh A, Kimura S, Roels J, Kuchmiy A, Strubbe S, Lawlor MA, da Silva-Diz V, Luo S, Gachet S, García-Prieto CA, Hagelaar R, Esteller M, Meijerink JPP, Soulier J, Taghon T, Van Vlierberghe P, Mullighan CG, Khiabanian H, Rocha PP, Herranz D. A Tumor Suppressor Enhancer of PTEN in T-cell development and leukemia. Blood Cancer Discov. 2021 Jan;2(1):92-109. PMID:33458694.

Zheng Y, Chen Z, Han Y, Han L, Zou X, Zhou B, Hu R, Hao J, Bai S, Xiao H, Li WV, Bueker A, Ma Y, Xie G, Yang J, Chen S, Li H, Cao J, Shen L. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment. Nat Commun. 2020 Dec 8;11(1):6268. PMID:33293583.

Clements KE, Schleicher EM, Thakar T, Hale A, Dhoonmoon A, Tolman NJ, Sharma A, Liang X, Imamura Kawasawa Y, Nicolae CM, Wang HG, De S, Moldovan GL. Identification of regulators of poly-ADP-ribose polymerase inhibitor response through complementary CRISPR knockout and activation screens. Nat Commun. 2020 Nov 30;11(1):6118. PMID:33257658.

Qu H, Wu P, Huang Q, Yi J, Yan Z, Li K, Riedlinger GM, De S, Zhang S, Metaxas DN. Weakly Supervised Deep Nuclei Segmentation Using Partial Points Annotation in Histopathology Images. IEEE Trans Med Imaging. 2020 Nov;39(11):3655-3666. PMID:32746112.

Hu X, Xu Z, De S. Characteristics of mutational signatures of unknown etiology. NAR Cancer. 2020 Sep;2(3):zcaa026. PMID:33015626.

Serei VD, Poplin E, Ganesan S, Riedlinger G. Molecular Profiling for Proper Diagnosis of Gastroenteropancreatic Neuroendocrine Tumor. JCO Precis Oncol. 2020 Jul 27;4:PO. PMID:32923901.

Cao J, Yan Q. Cancer Epigenetics, Tumor Immunity, and Immunotherapy. Trends Cancer. 2020 Jul;6(7):580-592. PMID:32610068.

Panda A, Rosenfeld JA, Singer EA, Bhanot G, Ganesan S. Genomic and immunologic correlates of LAG-3 expression in cancer. Oncoimmunology. 2020 May 22;9(1):1756116. PMID:32923111.

Loh JW, Guccione C, Di Clemente F, Riedlinger G, Ganesan S, Khiabanian H. All-FIT: allele-frequency-based imputation of tumor purity from high-depth sequencing data. Bioinformatics. 2020 Apr 1;36(7):2173-2180. PMID:31750888.

Cai WL, Greer CB, Chen JF, Arnal-Estapé A, Cao J, Yan Q, Nguyen DX. Specific chromatin landscapes and transcription factors couple breast cancer subtype with metastatic relapse to lung or brain. BMC Med Genomics. 2020 Mar 6;13(1):33. PMID:32143622.

Feng X, Lu H, Yue J, Schneider N, Liu J, Denzin LK, Chan CS, De S, Shen Z. Loss of Setd4 delays radiation-induced thymic lymphoma in mice. DNA Repair (Amst). 2020 Feb;86:102754. PMID:31794893.

Sokol ES, Pavlick D, Khiabanian H, Frampton GM, Ross JS, Gregg JP, Lara PN, Oesterreich S, Agarwal N, Necchi A, Miller VA, Alexander B, Ali SM, Ganesan S, Chung JH. Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity. JCO Precis Oncol. 2020;4:442-465. PMID:32903788.

Santana LM, Ganesan S, Bhanot G. A Quasi Birth-and-Death model for tumor recurrence. J Theor Biol. 2019 Nov 7;480:175-191. PMID:31374283.


All Publications on PubMed